MENU
+Compare
NVYTF
Stock ticker: OTC
AS OF
Nov 12 closing price
Price
$0.51
Change
-$0.00 (-0.00%)
Capitalization
35.95M

NVYTF Novacyt Clamart Forecast, Technical & Fundamental Analysis

Novacyt SA is engaged in developing and selling diagnostic products for cancer and infectious diseases... Show more

NVYTF
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for NVYTF with price predictions
Nov 12, 2025

NVYTF's Stochastic Oscillator descends into oversold zone

The Stochastic Oscillator for NVYTF moved into oversold territory on November 12, 2025. Be on the watch for the price uptrend or consolidation in the future. At that time, consider buying the stock or exploring call options.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

NVYTF moved above its 50-day moving average on October 16, 2025 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for NVYTF crossed bullishly above the 50-day moving average on October 16, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 12 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The RSI Indicator demonstrates that the ticker has stayed in the overbought zone for 11 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.671) is normal, around the industry mean (63.534). P/E Ratio (0.000) is within average values for comparable stocks, (37.086). NVYTF's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.687). NVYTF has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.019). P/S Ratio (1.408) is also within normal values, averaging (79.919).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. NVYTF’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. NVYTF’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock worse than average.

View a ticker or compare two or three
NVYTF
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Industry MedicalNursingServices

Profile
Fundamentals
Details
Industry
N/A
Address
13, Avenue Morane Saulnier
Phone
+33 139465104
Employees
222
Web
https://www.novacyt.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AMQFF0.250.01
+3.26%
ABITIBI METALS CORP.
ARSEF0.04N/A
N/A
Altai Resources Inc.
KRYAF93.00N/A
N/A
Kerry Group plc
SRXXF9.40N/A
N/A
SPARX Asset Management Co., Ltd.
VRLAF29.74N/A
N/A
VERALLIA, COURBEVOIE

NVYTF and Stocks

Correlation & Price change

A.I.dvisor tells us that NVYTF and ARAY have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that NVYTF and ARAY's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NVYTF
1D Price
Change %
NVYTF100%
N/A
ARAY - NVYTF
31%
Poorly correlated
+0.85%
PRCT - NVYTF
21%
Poorly correlated
-1.82%
POCI - NVYTF
3%
Poorly correlated
-0.60%
OCPNF - NVYTF
1%
Poorly correlated
+10.15%
NNCSF - NVYTF
0%
Poorly correlated
N/A
More

Groups containing NVYTF

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NVYTF
1D Price
Change %
NVYTF100%
N/A
Health Services
category (422 stocks)
-0%
Poorly correlated
+0.18%
Medical/Nursing Services
category (215 stocks)
-5%
Poorly correlated
+0.36%